Warren Neil Sprigings

Warren’s practice has focused on litigation in the pharmaceutical industry including Patented Medicines (Notice of Compliance) proceedings, patent infringement / validity proceedings, trademark actions and oppositions and damage quantifications. Warren is a registered Canadian Patent and Trademark Agent, as well as a registered U.S. Patent Agent. His experience includes drafting and prosecuting patent and trademark applications.

Application under subsection 6(1) of the Patented Medicines (Notice of Compliance) Regulations regarding apalutamide.

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,733,908 (ivacaftor).

Action under section 8.2 of the Patented Medicines (Notice of Compliance) Regulations regarding apalutamide.

Application under subsection 6(1) of the Patented Medicines (Notice of Compliance) Regulations regarding aflibercept.

Action under section 8.2 of the Patented Medicines (Notice of Compliance) Regulations regarding aflibercept.